Sort
16,179 grants matching “malaria”
Development of an anti-malaria toxin vaccine candidate
$1,066,844Ancora Pharmaceuticals, Inc. · R44 · FY2005 · AI
Activation of Human Natural Killer Cell Function
$1,066,211Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES
$1,064,685David S. Roos · University Of Pennsylvania · N01 · FY2017 · AI
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection
$1,062,400L David Sibley · Washington University · R01 · FY2020 · AI
Malaria Parasite Ligands And Host Cell Receptors
$1,060,999Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Evolutionary Analysis and Comparative Genomics of Protein Superfamilies
$1,060,673Aravind Iyer · National Library Of Medicine · ZIA · FY2014 · LM
Malaria Transmission Blocking Vaccine Discovery
$1,059,874Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Clinical and translational evaluation of vector saliva based vaccination strategies for Zika and other important or emerging vector-borne diseases
$1,058,474Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Impact of Environmental Modifications on Vector Ecology and Transmission of Plasmodium falciparum and P. vivax Malaria
$1,057,861Guiyun Yan · University Of California-Irvine · U19 · FY2022 · AI
Point of Care Breath Test to Screen for Sickle Cell Disease in Developing Nations
$1,057,282Anish Bhatnagar · Soleno Therapeutics, Inc. · R44 · FY2017 · HL
Development of Pre-Erythrocytic Malaria Vaccines and antibodies
$1,056,433Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development of Pre-Erythrocytic Malaria Vaccines and antibodies
$1,056,433Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
India International Center for Excellence in Research
$1,056,353Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Assay Work for Malaria Vaccines - VTEU
$1,056,336Daniel Hoft · Saint Louis University · N01 · FY2015 · AI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria
$1,056,231Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2007 · AI
Center for the Study of Complex Malaria in India
$1,055,500Jane Carlton · New York University · U19 · FY2021 · AI
Center for the Study of Complex Malaria in India
$1,055,500Jane Carlton · New York University · U19 · FY2021 · AI
Optimized Combination Antimalarial Drug Therapy
$1,055,093Paul D. Roepe · Georgetown University · R01 · FY2014 · AI
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
$1,054,247Wendy Prudhommeomeara · Duke University · R01 · FY2025 · AI
India International Center for Excellence in Research
$1,053,276Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Task 4: The Interventional Agent Development Services program
$1,052,978Norman Kneteman · Sri International · N01 · FY2013 · AI
BIOMECHANICAL CONSTRAINTS AND TRADE-OFFS BETWEEN SUGAR AND BLOOD FEEDING IN MOSQUITOES
$1,051,867Chloé Lahondère · Virginia Polytechnic Institute And State University · · FY2021 · BIO
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,051,597Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Peptide-Protein Conjugate Vaccines
$1,051,592Rachel Schneerson · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Impact of gene-drive systems for population modification on malaria vector mosquitoes
$1,050,871Anthony A James · University Of California-Irvine · R01 · FY2024 · AI